4.5 Review

Chronic kidney disease and the gut microbiome

Journal

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
Volume 316, Issue 6, Pages F1211-F1217

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajprenal.00298.2018

Keywords

chronic kidney disease; disease progression; gastrointestinal tract; indoxyl sulfate; metaproteomics; microbiome

Funding

  1. Department of Veterans Affairs
  2. National Institute of Diabetes and Digestive and Kidney Diseases [1R01 DK-101034]
  3. National Institute of General Medical Sciences Institutional Development Award Centers of Biomedical Research Excellence Grant [1-P20-GM-121293]

Ask authors/readers for more resources

The gut microbiome is composed of a diverse population of bacteria that have beneficial and adverse effects on human health. The microbiome has recently gained attention and is increasingly noted to play a significant role in health and a number of disease states. Increasing urea concentration during chronic kidney disease (CKD) leads to alterations in the intestinal flora that can increase production of gut-derived toxins and alter the intestinal epithelial harrier. These changes can lead to an acceleration of the process of kidney injury. A number of strategies have been proposed to interrupt this pathway of injury in CKD. The purpose of this review is to summarize the role of the gut microbiome in CKD, tools used to study this microbial population, and attempts to alter its composition for therapeutic purposes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available